Stalicla Company

STALICLA is a Swiss biotechnology company developing precision medicine treatments for patients with Neurodevelopmental disorders

Investors

Technology: Pharmaceuticals
Industry: Clinical development, NeuroTech
Headquarters: Genève, Geneve, Switzerland
Founded Date: 2017-05-01
Employees Number: 11-50
Funding Status: Early Stage Venture
Investors Number: 1
Total Funding: 33460000
Estimated Revenue: $1M to $10M
Last Funding Date: 2022-12-01
Last Funding Type: Convertible Note

Visit Website
Register and Claim Ownership